Print

HVTN 098

A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of PENNVAX?-GP (Gag, Pol, Env) DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adult Participants

Trial Details:

I Ongoing
HIV Vaccine Trials Network (HVTN); NIAID April 01, 2015
PENNVAX-GP Gag, Pol, Env B
PENNVAX-GP DNA
IL-12 DNA adjuvant
USA 94
NCT02431767
https://www.clinicaltrials.gov/ct2/show/NCT02431767?term=hiv+and+vaccine&lup_s=04%2F20%2F2015&lup_d=14&show_rss=Y&sel_rss=mod14